Macusoft

Macusoft is a London-based health technology company developing AI-powered software to support clinical decision-making in ophthalmology.

Its platform assists with diagnosis, triage, and treatment recommendations for macular diseases, diabetic retinopathy, and related retinal conditions, drawing on imaging data and genomics.

The company has received Innovate UK funding and has been trialled at Guy's and St Thomas' NHS Foundation Trust.

Macusoft has participated in accelerator programmes at the Francis Crick Institute and Imperial College London.